PMH28 Using Cost-Effectiveness Analysis to Define the Optimal Group of Patients to Benefit From Risperidone Long-Acting Injectable

✍ Scribed by A. Valencia-Mendoza; A. Hernández-Garduño

• Book ID: 119312771
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 72 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.08.818